Lumos Pharma, Inc.盘中异动早盘股价大跌5.81%报3.08美元

自选股智能写手08-19

北京时间2024年08月19日21时32分，Lumos Pharma, Inc.（LUMO.us）股票出现异动，股价急速下跌5.81%。截至发稿，该股报3.08美元/股，成交量2.8409万股，换手率0.35%，振幅2.14%。最近的财报数据显示，该股实现营业收入488000.00美元，净利润-7.55百万美元，每股收益-0.93美元，毛利486000.00美元，市盈率-0.70倍。机构评级方面，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2460349350?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-19 21:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2460349350","market":"us","top_or_hot":-1,"title":"Lumos Pharma, Inc.盘中异动 早盘股价大跌5.81%报3.08美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年08月19日21时32分，Lumos Pharma, Inc.（LUMO.us）股票出现异动，股价急速下跌5.81%。截至发稿，该股报3.08美元/股，成交量2.8409万股，换手率0.35%，振幅2.14%。最近的财报数据显示，该股实现营业收入488000.00美元，净利润-7.55百万美元，每股收益-0.93美元，毛利486000.00美元，市盈率-0.70倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921323095a7167d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lumos Pharma, Inc.盘中异动 早盘股价大跌5.81%报3.08美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLumos Pharma, Inc.盘中异动 早盘股价大跌5.81%报3.08美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-19 21:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921323095a7167d&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年08月19日21时32分，Lumos Pharma, Inc.（LUMO.us）股票出现异动，股价急速下跌5.81%。截至发稿，该股报3.08美元/股，成交量2.8409万股，换手率0.35%，振幅2.14%。最近的财报数据显示，该股实现营业收入488000.00美元，净利润-7.55百万美元，每股收益-0.93美元，毛利486000.00美元，市盈率-0.70倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921323095a7167d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ALZN","symbol_name":"Alzamend Neuro, Inc","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921323095a7167d&s=b","article_id":"2460349350","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921323095a7167d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2460349350","pubTimestamp":1724074350,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年08月19日21时32分，Lumos Pharma, Inc.股票出现异动，股价急速下跌5.81%。Lumos Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Cingulate Inc.较为活跃，换手率分别为2081.55%、1354.76%、304.62%，振幅较大的相关个股有Alzamend Neuro, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Virax Biolabs Group Limited，振幅分别为42.64%、42.07%、34.74%。Lumos Pharma, Inc.公司简介：Lumos Pharma Inc是一家生物制药公司，致力于开发治疗癌症和罕见疾病的治疗方法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ALZN":"Alzamend Neuro, Inc","BK4539":"次新股","LUMO":"Lumos Pharma Inc.","BK4139":"生物科技"},"translate_title":"Intraday changes in Lumos Pharma, Inc. shares fell 5.81% to $3.08 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LUMO":0.9,"ALZN":0.86},"content_text":"北京时间2024年08月19日21时32分，Lumos Pharma, Inc.（LUMO.us）股票出现异动，股价急速下跌5.81%。截至发稿，该股报3.08美元/股，成交量2.8409万股，换手率0.35%，振幅2.14%。最近的财报数据显示，该股实现营业收入488000.00美元，净利润-7.55百万美元，每股收益-0.93美元，毛利486000.00美元，市盈率-0.70倍。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Lumos Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Geovax Labs Inc C/Wts 29/09/2025(To Pur Com)涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Cingulate Inc.较为活跃，换手率分别为2081.55%、1354.76%、304.62%，振幅较大的相关个股有Alzamend Neuro, Inc.、Geovax Labs Inc C/Wts 29/09/2025(To Pur Com)、Virax Biolabs Group Limited，振幅分别为42.64%、42.07%、34.74%。Lumos Pharma, Inc.公司简介：Lumos Pharma Inc是一家生物制药公司，致力于开发治疗癌症和罕见疾病的治疗方法。 它对一系列有助于免疫系统对抗癌细胞的分子进行临床阶段和临床前研究。 该疗法可口服，并可与其他癌症疗法结合使用。 公司还研究埃博拉疫苗。Lumos与生产组织签订合同，生产治疗药物，与制药公司建立合作关系，主要在美国运营。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2460349350"}

Lumos Pharma, Inc.盘中异动 早盘股价大跌5.81%报3.08美元

精彩评论

Lumos Pharma, Inc.盘中异动早盘股价大跌5.81%报3.08美元